ANCA vasculitis: Wegener's granulomatosis, NF-kB and Ginger

Vasculitis associated with ANCA (Anti-Neutrophil Cytoplasmic Antibodies) mainly includes granulomatosis with polyangiitis (GPA, formerly Wegener's disease), microscopic polyangiitis (PAM) and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss). These are rare but potentially fatal diseases, with renal, pulmonary and neurological damage.

Mechanisms of ANCA Vasculitis: The Central Role of NF-kB

ANCAs (anti-PR3 in GPA, anti-MPO in PAM) are autoantibodies that directly activate neutrophils:

1. Neutrophils primed by cytokines (TNF-α, IL-18) express PR3 and MPO on their surface
2. ANCAs bind to these antigens → activation of neutrophils → NETosis (release of NETs loaded with DNA and PR3/MPO)
3. NETs activate endothelial cells → NF-kB → expression of adhesion molecules and cytokines → recruitment of polynuclear cells and monocytes
4. Perivascular granulomas → tissue destruction (kidneys, lungs, ENT, nerves)
5. IL-17A (Th17): amplifies neutrophilic recruitment and ANCA production

Gingerol and the Mechanisms of ANCA Vasculitis

Several targets of gingerol are relevant in ANCA vasculitis:

• Inhibition of NETosis: gingerol reduces the release of NETs by activated neutrophils (anti-inflammatory-inflammation-natural-remedy">Inflammation Research, 2021) — directly relevant in ANCA vasculitis where NETosis is central
• Inhibition of endothelial NF-kB: ↓ VCAM-1, ICAM-1, E-selectin → less neutrophilic recruitment in the vascular wall
• Anti-Th17: ↓ IL-17A via inhibition of RORγt and STAT3 → less amplification of neutrophilic recruitment
• Reduction of TNF-α: TNF-α is the cytokine that primes neutrophils for activation by ANCA — gingerol reduces TNF-α by 40-70%

Essential Clinical Position

ANCA vasculitides are life-threatening diseases. Induction treatment is based on rituximab or cyclophosphamide + corticosteroids. INTI is not a treatment for ANCA vasculitis — it is potentially a very modest adjuvant in the maintenance phase. Caution is absolutely necessary: patients on immunosuppressants should discuss any supplements with their nephrologist/rheumatologist.

Practical Note

ANCA patients undergoing maintenance on azathioprine or rituximab often have dietary and metabolic restrictions. INTI with 1.19g of sugar per 100ml and its profile anti-inflammatory ginger natural is compatible with most protocols, subject to medical validation. GIMBER with 35g/100ml should be avoided, particularly in the case of corticosteroids.ginger diabetes associated.

Conclusion

ANCA vasculitides involve NF-kB, NETosis, Th17 and TNF-α — all targets of gingerol. Although specific clinical data are lacking, the mechanistic consistency is real. INTI can be considered as a general anti-inflammatory supplement in the maintenance phase, with prior medical validation.

Strictly informative article. ANCA vasculitis requires specialized immunosuppressive treatment. Consult your nephrologist or rheumatologist before any supplement.